Device Biliary Stent Introducer_endo

Biliary Stent Introducer

Payments companies reported to CMS as associated with Biliary Stent Introducer. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$3,665associated payments (2023-2025)
33clinicians with associated payments
1company reporting

By year

2023 $48.94
2024 $379
2025 $3,236

Payments reported as associated with Biliary Stent Introducer, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Gastroenterology (Internal Medicine) $2,711
Internal Medicine $179
Physical Medicine & Rehabilitation $146
Physician Assistant $146
Pediatric Gastroenterology $146
Anatomic Pathology & Clinical Pathology $17.07

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Biliary Stent Introducer

These are the largest totals companies reported as associated with Biliary Stent Introducer. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Simon Lo Los Angeles, CA Gastroenterology (Internal Medicine) $292.88
Lionel Dsouza East Setauket, NY Gastroenterology (Internal Medicine) $146.44
Kartik Sampath New York, NY Gastroenterology (Internal Medicine) $146.44
Hyun Kim San Diego, CA Gastroenterology (Internal Medicine) $146.44
Cynthia Akagbosu New York, NY Pediatric Gastroenterology $146.44
Srinivas Puli Fort Worth, TX Gastroenterology (Internal Medicine) $146.44
Petros Benias New, NY Gastroenterology (Internal Medicine) $146.44
Aiya Aboubakr New York, NY Gastroenterology (Internal Medicine) $146.44
Patrick Magahis Boston, MA Internal Medicine $146.44
Jeffrey Lee Stockbridge, GA Physical Medicine & Rehabilitation $146.44

Prescribed Biliary Stent Introducer?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.